Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EpiPen
Pharma
Another EpiPen antitrust settlement costs Pfizer $50M
Pfizer has agreed to pay $50M to resolve an antitrust case which alleged it teamed up with other companies to delay EpiPen generics.
Kevin Dunleavy
Oct 11, 2023 6:03pm
ARS hits major setback in bid to launch epinephrine newcomer
Sep 20, 2023 10:31am
Meridian, Kindeva invest $100M in new site in Missouri
Apr 12, 2023 11:33am
Viatris spared from EpiPen investor lawsuit in New York
Apr 3, 2023 10:40am
EpiPen litigation comes back to haunt Teva
Dec 6, 2022 10:20am
Kindeva, former Pfizer unit merge to form drug-device CDMO
Nov 16, 2022 2:54pm